Fürst Medical Laboratory completed the acquisition of PatoGen.

Fürst Medical Laboratory, a provider of medical laboratory testing services, completed the acquisition of PatoGen, a provider of laboratory and biotechnology research services. Financial terms were not disclosed. "Fürst has a long lasting and solid experience running effective laboratories and diagnostics. Becoming owners of PatoGen, we also get exposure to preventive and diagnostic analyses in fish. This is an attractive market for us, and we are confident we can make a valuable contribution to the aquaculture companies to improve their fish health and fish welfare," Selby Ebbestad, Fürst CEO.